BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 21517976)

  • 1. Biomarker strategies to predict need for renal replacement therapy in acute kidney injury.
    Cruz DN; de Geus HR; Bagshaw SM
    Semin Dial; 2011; 24(2):124-31. PubMed ID: 21517976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of renal function, which and when?
    Wasung ME; Chawla LS; Madero M
    Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Biomarkers of Acute Kidney Injury After Contrast Coronary Angiography.
    Connolly M; McEneaney D; Menown I; Morgan N; Harbinson M
    Cardiol Rev; 2015; 23(5):240-6. PubMed ID: 25699983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel biomarkers of acute kidney injury and failure: clinical applicability.
    Mårtensson J; Martling CR; Bell M
    Br J Anaesth; 2012 Dec; 109(6):843-50. PubMed ID: 23048068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for acute kidney injury in critically ill patients.
    Gonzalez F; Vincent F
    Minerva Anestesiol; 2012 Dec; 78(12):1394-403. PubMed ID: 23032924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of renal replacement therapy in acute kidney injury.
    Oppert M
    Minerva Urol Nefrol; 2016 Feb; 68(1):72-7. PubMed ID: 26583593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature.
    Vanmassenhove J; Vanholder R; Nagler E; Van Biesen W
    Nephrol Dial Transplant; 2013 Feb; 28(2):254-73. PubMed ID: 23115326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of neutrophil gelatinase-associated lipocalin in identifying critically ill patients with acute kidney injury stage 2-3 who subsequently require renal replacement therapy.
    Tiranathanagul K; Amornsuntorn S; Avihingsanon Y; Srisawat N; Susantitaphong P; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    Ther Apher Dial; 2013 Jun; 17(3):332-8. PubMed ID: 23735150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of kidney injury.
    Urbschat A; Obermüller N; Haferkamp A
    Biomarkers; 2011 Jul; 16 Suppl 1():S22-30. PubMed ID: 21707441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of acute kidney injury: an evolving domain.
    McIlroy DR; Wagener G; Lee HT
    Anesthesiology; 2010 Apr; 112(4):998-1004. PubMed ID: 20216399
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular markers for ischemia, do we have something better then creatinine and glomerular filtration rate?
    Sprenkle P; Russo P
    Arch Esp Urol; 2013; 66(1):99-114. PubMed ID: 23406805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for the early detection of acute kidney injury.
    Nguyen MT; Devarajan P
    Pediatr Nephrol; 2008 Dec; 23(12):2151-7. PubMed ID: 17394022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic test for early detection of acute kidney injury.
    Hollmen M
    Expert Rev Mol Diagn; 2011 Jul; 11(6):553-5. PubMed ID: 21745008
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of novel biomarkers in early diagnosis and prognosis of acute kidney injury in newborns.
    Argyri I; Xanthos T; Varsami M; Aroni F; Papalois A; Dontas I; Fanos V; Iacovidou N
    Am J Perinatol; 2013 May; 30(5):347-52. PubMed ID: 23023560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The early diagnosis of acute renal graft dysfunction: a challenge we face. The role of novel biomarkers.
    Halawa A
    Ann Transplant; 2011; 16(1):90-8. PubMed ID: 21436782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis.
    Klein SJ; Brandtner AK; Lehner GF; Ulmer H; Bagshaw SM; Wiedermann CJ; Joannidis M
    Intensive Care Med; 2018 Mar; 44(3):323-336. PubMed ID: 29541790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma Neutrophil Gelatinase-Associated Lipocalin (NGAL) predicts acute kidney injury in septic shock at ICU admission].
    Camou F; Oger S; Paroissin C; Guilhon E; Guisset O; Mourissoux G; Pouyes H; Lalanne T; Gabinski C
    Ann Fr Anesth Reanim; 2013 Mar; 32(3):157-64. PubMed ID: 23453486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel biomarkers for the prediction of acute kidney injury in patients undergoing liver transplantation.
    Dedeoglu B; de Geus HR; Fortrie G; Betjes MG
    Biomark Med; 2013 Dec; 7(6):947-57. PubMed ID: 24266830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil gelatinase-associated lipocalin curve and neutrophil gelatinase-associated lipocalin extended-range assay: a new biomarker approach in the early diagnosis of acute kidney injury and cardio-renal syndrome.
    Ronco C; Cruz D; Noland BW
    Semin Nephrol; 2012 Jan; 32(1):121-8. PubMed ID: 22365170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neutrophil gelatinase-associated lipocalin (NGAL) in patients with Shiga toxin mediated haemolytic uraemic syndrome (STEC-HUS).
    Lukasz A; Beneke J; Menne J; Vetter F; Schmidt BM; Schiffer M; Haller H; Kümpers P; Kielstein JT
    Thromb Haemost; 2014 Feb; 111(2):365-72. PubMed ID: 24172823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.